Background Irritable bowel syndrome (IBS) is the most common functional digestive
condition in the industrialized world. The gut microbiota plays a key role in disease …

Background & Aims Irritable bowel syndrome (IBS) is common but difficult to treat. Altering
the gut microbiota has been proposed as a strategy for treatment of IBS, but the association …

Abstract Background and Aims Alterations of gut microbiota were assumed to be the etiology
and pathogenesis of irritable bowel syndrome (IBS) in some studies. However, alterations of …

Background Irritable bowel syndrome (IBS) is a prevalent gastrointestinal disease with a
substantial social and economic burden. Treatment options remain limited and research on …

Irritable bowel syndrome and gut microbiota : Current Opinion in Endocrinology, Diabetes
and Obesity Irritable bowel syndrome and gut microbiota : Current Opinion in Endocrinology …

Irritable bowel syndrome (IBS) is one of the most common functional gastrointestinal
disorders encountered in clinical practice. It is a heterogeneous disorder with a multifactorial …

The intestinal microbiota is one of the most rapidly evolving areas in biology and medicine.
Extensive research in the last decade has escalated our understanding of the role of the …

Background Growing evidence has suggested that gut microbiota is closely related to the
risk of irritable bowel syndrome (IBS), but whether there is a causal effect remains unknown …

Background Enteric microbiota is increasingly being recognized as an important factor in the
pathogenesis of irritable bowel syndrome (IBS). The reported prevalence of small intestinal …

Irritable bowel syndrome (IBS) is a heterogeneous functional disorder with a multifactorial
etiology that involves the interplay of both host and environmental factors. Among …